1D-LSD Pellets – 225mcg
€ 87,50 – € 930,00Price range: € 87,50 through € 930,00
1D-LSD Pellets 225mcg are described as compressed research units associated with 1D-LSD, an N1-acylated derivative of lysergic acid diethylamide.
The supplied source identifies the compound as 1-(1,2-dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide, a synthetic lysergamide structurally related to LSD.
The product is presented in a pellet format with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.
Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related lysergamide derivatives.
The source refers to ingredient purity of at least 98% where verified, together with HPLC or mass-spectrometric analysis, batch identification, and Certificate of Analysis documentation.
However, no actual batch-specific analytical report or supporting certificate was supplied.
The ingredient purity, finished-unit analyte content, content uniformity, excipient composition, chemical form, and stereochemical identity remain unverified.
The pellets are not established as certified reference materials or validated quantitative calibration standards.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
1D-LSD Pellets 225mcg – Lysergamide Research Material
1D-LSD Pellets 225mcg – Product Overview
1D-LSD Pellets 225mcg is the supplied catalog designation for a pellet-format research preparation associated with 1D-LSD.
The named compound belongs to the lysergamide family and is structurally related to lysergic acid diethylamide.
Its molecular structure differs from LSD through the presence of an N1-acyl substituent derived from a dimethylcyclobutane carbonyl group.
The supplied source presents the product as compressed pellets intended for controlled analytical and non-clinical laboratory research.
Each finished pellet is described as having a labeled analyte quantity.
However, no actual finished-unit assay or content-uniformity report accompanied the information.
The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.
The supplied scientific context includes chemical identification, chromatographic characterization, structural comparison, and research involving related lysergamide derivatives.
These research contexts should be distinguished from verified findings about the actual finished pellets.
No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.
The source also refers to HPLC or mass-spectrometric verification, batch identification, and Certificate of Analysis documentation.
These statements remain unverified without supporting records.
The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.
Chemical Identity & Classification
The supplied source identifies 1D-LSD as 1-(1,2-dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide.
It is an N1-acylated lysergamide structurally related to LSD.
The dimethylcyclobutane-derived acyl substituent distinguishes the named compound from LSD and other N1-acylated derivatives.
The supplied chemical information includes:
- Common designation: 1D-LSD
- Descriptive chemical name: 1-(1,2-Dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide
- Chemical classification: N1-acylated lysergamide
- Reported presentation: Compressed pellets
- Labeled analyte amount: Specified per finished pellet
- Intended designation: Research Use Only
The supplied source does not provide a verified CAS Registry Number, molecular formula, molecular weight, or complete stereochemical characterization for the actual batch.
These identifiers should not be inferred from related lysergamide compounds.
The molecular structure of the named compound does not establish the composition of the finished pellet preparation.
Additional formulation components may be present, but the source does not identify them.
The chemical form, including any salt or solvate composition, also remains unconfirmed.
Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.
Chemical & Physical Characteristics
The supplied source describes the product as solid pellets.
A pellet is a finished preparation in which the named analyte may be combined with additional formulation components.
The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.
The source does not identify the excipient composition, pellet dimensions, total unit mass, manufacturing method, or surface characteristics.
No actual product-specific physical inspection report or finished-unit composition record was supplied.
The named compound contains an N1-acyl substituent derived from a dimethylcyclobutane carbonyl group.
This structural feature distinguishes 1D-LSD from LSD and from related derivatives containing different N1-acyl groups.
The source does not provide experimentally verified solubility measurements or product-specific solvent compatibility records.
No validated extraction or analytical recovery characteristics of the finished pellets can therefore be established from the supplied information.
The source also does not establish the distribution of analyte throughout the compressed formulation. 1D-LSD Pellets 225mcg
Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.
The source recommends cool, dry, light-protected storage.
No validated product-specific stability study accompanied that recommendation.
Purity & Analytical Verification
The supplied source refers to ingredient purity of at least 98% where verified.
However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.
The reported purity threshold therefore remains a supplier-provided claim rather than an independently verified result.
The source refers to HPLC and mass spectrometry as analytical verification methods.
No chromatogram, mass spectrum, impurity profile, or independent laboratory certificate was supplied.
Accordingly, no specific purity result can be confirmed for the actual product batch.
For 1D-LSD Pellets 225mcg, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.
An ingredient-purity result does not independently establish finished-unit content or content uniformity.
The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.
The material is described in reference-oriented research terms.
However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.
The finished pellets should therefore not be represented as certified quantitative reference standards. 1D-LSD Pellets 225mcg
Any definitive analytical claims require actual supporting batch records.
Quality Control & Batch Integrity
The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.
They therefore remain unverified supplier claims.
For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history. 1D-LSD Pellets 225mcg
For 1D-LSD Pellets 225mcg, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified analyte content, excipient composition, or content uniformity.
The source also does not provide evidence that every finished pellet meets a particular quantitative specification. 1D-LSD Pellets 225mcg
The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.
Claims concerning batch consistency and validated analytical performance should be supported by actual records.
Safety, Handling & Laboratory Precautions
1D-LSD is a synthetic lysergamide associated with significant pharmacological activity and potential toxicological uncertainty.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The pellet presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, ingredient purity, excipient composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes discreet packaging, batch-aware handling, tracking, and protective shipment arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends storage in a sealed, airtight container in a cool, dry environment protected from light.
It also refers to refrigeration as a recommended precaution.
No validated product-specific stability study was supplied to establish a verified storage temperature or to support a particular shelf life.
For 1D-LSD Pellets 225mcg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.
The labeled analyte quantity should be recorded as a source-provided specification unless independently verified. 1D-LSD Pellets 225mcg
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.
Intended Research Use & Market Positioning
The supplied scientific context places 1D-LSD within analytical research involving lysergamide chemical identity, N1-acyl substitution, and comparative structural characterization.
The dimethylcyclobutane-derived acyl substituent provides a distinguishing structural feature relevant to chemical analysis.
The source also describes interest in chromatographic profiling, analytical method development, and non-clinical laboratory research.
However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual pellets.
The Raw Lab Chems catalog identifies 1D-LSD Pellets as the product listing discussed here.
For related product-format context, the supplied catalog also includes 1D-LSD Micro Pellets and 1V-LSD Blotters.
The first related listing refers to the same named compound in a different labeled pellet format.
The second refers to 1V-LSD, a different N1-acylated lysergamide.
1D-LSD and 1V-LSD should not be treated as chemically identical or analytically interchangeable.
The supplied information does not establish equivalent chemical purity, analyte content, excipient composition, substrate composition, or content uniformity across these preparations.
These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.
It also identifies possible labeled pack sizes.
No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.
Consequently, no availability, pack-size, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted. 1D-LSD Pellets 225mcg
1D-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. 1D-LSD Pellets 225mcg
1D-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (pellets) |
5 ,10 ,25 ,50 ,100 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.